GO:0019864 IgG binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019864 (IgG binding) is a molecular function defined as binding to an immunoglobulin of an IgG isotype.
• Key IgG-binding proteins include FcRn, Fcγ receptors, protein A/G, and pathogen-derived IgG-binding proteins such as HSV-2 gE and streptococcal proteins.
• IgG binding is critical for maternofetal IgG transfer, antibody effector functions, and immune evasion by pathogens.
• The interaction between FcRn and IgG is pH-dependent and occurs independently at both sites of the IgG homodimer.
• Dysregulation of IgG binding contributes to autoimmune diseases, infections, and influences therapeutic antibody pharmacokinetics.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable precise dissection of IgG-binding mechanisms and therapeutic targeting.
Description
GO:0019864, IgG binding, is a molecular function that describes the selective interaction of a protein or molecular complex with an immunoglobulin of the IgG isotype. This function is central to humoral immunity, as IgG is the most abundant antibody class in human serum and mediates diverse effector functions through binding to Fc receptors and other IgG-binding molecules. Understanding IgG binding is essential for immunology, infectious disease research, and therapeutic antibody development. The interaction between IgG and its binding partners, such as the neonatal Fc receptor (FcRn), governs antibody half-life, placental transfer, and antigen clearance. Pathogens have evolved IgG-binding proteins to evade host immunity, as exemplified by HSV-2 glycoprotein E and group A Streptococcus proteins. Moreover, engineered IgG-binding proteins and pH-sensitive variants are valuable tools for biotechnology and medicine. This article provides a comprehensive overview of the molecular mechanisms, key genes, disease relevance, and research methodologies associated with GO:0019864, optimized for both human readers and AI-driven retrieval systems.
IgG binding At A Glance
| GO ID | GO:0019864 |
|---|---|
| GO term | IgG binding |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Binding to an immunoglobulin of an IgG isotype. |
| Major function | Mediates interactions with IgG antibodies for immune recognition, transport, and effector functions. |
| Key examples | FcRn, FcγRI, FcγRII, FcγRIII, protein A, protein G, HSV-2 gE, streptococcal proteins. |
| Cellular location | Cell surface, endosomes, extracellular space. |
| Related diseases | Autoimmunity, infections, placental transfer disorders, therapeutic antibody clearance. |
What Is GO:0019864?
According to the Gene Ontology, GO:0019864 (IgG binding) is defined as the molecular function of binding to an immunoglobulin of an IgG isotype. This term encompasses any protein or molecular entity that selectively interacts with the Fc or Fab regions of IgG antibodies, including classical Fcγ receptors, the neonatal Fc receptor (FcRn), bacterial proteins such as protein A and protein G, and viral IgG-binding proteins. The binding event can occur at the cell surface, in endosomes, or in extracellular fluids, and it often triggers downstream signaling, transport, or immune modulation.
Why Is IgG binding Important in Cell Biology?
IgG binding is fundamental to both protective immunity and disease pathogenesis. It enables the transport of maternal IgG across the placenta, a process essential for neonatal immunity. It also mediates antibody-dependent cellular cytotoxicity and phagocytosis through Fcγ receptors. Pathogens exploit IgG binding to evade immune detection, as seen with HSV-2 gE and group A Streptococcus. In therapeutic settings, IgG binding to FcRn determines antibody half-life and is a key consideration in antibody engineering. Thus, studying GO:0019864 is critical for vaccine development, autoimmune disease research, and the design of therapeutic antibodies.
• Facilitates maternofetal transfer of IgG, providing passive immunity to the fetus and newborn.
• Mediates antibody effector functions through Fcγ receptors on immune cells.
• Regulates serum half-life of IgG via pH-dependent binding to FcRn.
• Enables pathogen immune evasion, e.g., HSV-2 gE binding to IgG-Fc.
• Contributes to autoimmune pathology through aberrant IgG-Fc receptor interactions.
• Influences the pharmacokinetics and efficacy of therapeutic monoclonal antibodies.
• Provides tools for biotechnology, such as protein A/G affinity purification.
• Serves as a target for vaccine design against IgG-binding pathogens.
• Plays a role in complement regulation by recruiting C4b-binding protein.
• Is essential for understanding species-specific differences in FcγR binding for preclinical testing.
Molecular Mechanism of IgG binding
IgG Structure and Binding Sites
In simple terms: IgG antibodies are Y-shaped molecules with two identical arms that can bind antigens and a stem that interacts with receptors.
IgG is a homodimeric immunoglobulin composed of two heavy and two light chains. The fragment crystallizable (Fc) region mediates binding to Fcγ receptors and FcRn, while the fragment antigen-binding (Fab) regions bind antigens. The Fc region contains two symmetric binding sites for FcRn, allowing independent binding with identical affinity. This structural arrangement is critical for the diverse functions of IgG binding, including immune complex formation and receptor crosslinking.
FcRn-Mediated pH-Dependent Binding
In simple terms: FcRn binds IgG in acidic environments and releases it at neutral pH, which is key for recycling and transport.
The neonatal Fc receptor (FcRn) binds the Fc portion of IgG in a pH-dependent manner, with high affinity at acidic pH (e.g., in endosomes) and low affinity at physiological pH. This property enables FcRn to rescue IgG from lysosomal degradation and transport it across cellular barriers, such as the placenta. Computational design has yielded pH-sensitive IgG-binding proteins that mimic this behavior. Albumin also binds FcRn but at distinct sites, highlighting the specificity of the FcRn-IgG interaction.
Fcγ Receptor Binding and Signaling
In simple terms: Fcγ receptors on immune cells recognize the Fc part of IgG and trigger cellular responses like phagocytosis.
Fcγ receptors (FcγRI, FcγRII, FcγRIII) bind the Fc region of IgG with varying affinities and mediate immune cell activation, phagocytosis, and cytokine release. The binding of human IgG to minipig FcγRs has been characterized to assess preclinical models for therapeutic antibodies. These interactions are crucial for antibody-dependent cellular cytotoxicity and are modulated by IgG subclass and glycosylation.
Pathogen-Derived IgG-Binding Proteins
In simple terms: Some pathogens produce proteins that bind IgG to hide from the immune system.
HSV-2 glycoprotein E (gE) binds the Fc region of IgG, forming immune complexes that evade complement and neutralization. Group A Streptococcus recruits C4b-binding protein via IgG binding, enhancing complement regulation and immune evasion. These pathogen-derived IgG-binding proteins are targets for vaccine development and therapeutic intervention.
Engineered and Synthetic IgG-Binding Proteins
In simple terms: Scientists have designed artificial proteins that bind IgG for research and medical applications.
Computational design has produced a pH-sensitive IgG-binding protein with potential for targeted delivery and purification. Bispecific IgG formats with four independent antigen-binding sites have been engineered to enhance avidity and functionality. These engineered proteins expand the toolkit for studying and exploiting IgG binding in biotechnology and medicine.
Key Genes Involved in GO:0019864 IgG binding
The following genes encode proteins that directly mediate or regulate IgG binding, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCGRT | Encodes FcRn alpha chain; binds IgG Fc pH-dependently | Determines IgG half-life and placental transfer |
| B2M | Beta-2-microglobulin; FcRn light chain | Essential for FcRn stability and function |
| FCGR1A | FcγRI (CD64); high-affinity IgG receptor | Mediates immune activation and phagocytosis |
| FCGR2A | FcγRIIA (CD32); low-affinity IgG receptor | Involved in immune complex clearance |
| FCGR2B | FcγRIIB (CD32B); inhibitory IgG receptor | Regulates B cell and myeloid cell activity |
| FCGR3A | FcγRIIIA (CD16a); mediates ADCC | Target for therapeutic antibody design |
| FCGR3B | FcγRIIIB (CD16b); GPI-anchored receptor | Modulates neutrophil function |
| ALB | Albumin; binds FcRn at distinct site | Competes with IgG for FcRn binding |
| SPA | Staphylococcal protein A; binds IgG Fc | Used in affinity chromatography |
| SPG | Streptococcal protein G; binds IgG Fc | Broad IgG-binding tool |
| HSV2_gE | HSV-2 glycoprotein E; binds IgG Fc | Immune evasion and vaccine target |
| C4BP | C4b-binding protein; recruited via IgG | Complement regulation by GAS |
| FCGR2C | FcγRIIC; expressed on NK cells | Modulates NK cell activity |
| FCGR1B | FcγRIB; putative receptor | Less characterized |
| FCGR2A_H131 | FCGR2A H131 allotype | Alters IgG binding affinity |
| FCGR2A_R131 | FCGR2A R131 allotype | Associated with autoimmune susceptibility |
| FCGR3A_V158 | FCGR3A V158 allotype | Higher affinity for IgG1 |
| FCGR3A_F158 | FCGR3A F158 allotype | Lower affinity for IgG1 |
How Is IgG binding Regulated?
IgG binding is regulated at multiple levels. The pH-dependent interaction between FcRn and IgG is controlled by endosomal pH gradients. Expression of Fcγ receptors is modulated by cytokines and immune activation. Pathogens can secrete IgG-binding proteins to modulate host immunity. Additionally, engineered pH-sensitive IgG-binding proteins can be designed to alter binding affinity in response to environmental cues.
IgG binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCGR2A | Autoimmune susceptibility | Knock-in of H131/R131 allotypes in mice |
| FCGR3A | ADCC efficiency | Point mutation V158F in NK cells |
| FCGRT | IgG half-life | Knockout mice for FcRn |
| HSV2_gE | Immune evasion | Overexpression in HSV-2 infection models |
| C4BP | Complement regulation | Knockout in group A Streptococcus models |
Autoimmune Diseases
Aberrant IgG binding to Fcγ receptors contributes to autoimmune pathology such as rheumatoid arthritis and systemic lupus erythematosus. FCGR2A and FCGR3A polymorphisms alter IgG affinity and influence disease susceptibility. Therapeutic strategies targeting FcγR-IgG interactions are under development.
Infectious Diseases
Pathogens like HSV-2 and group A Streptococcus express IgG-binding proteins to evade immune clearance. HSV-2 gE binds IgG-Fc to inhibit complement and neutralization. GAS recruits C4b-binding protein via IgG to downregulate complement. These mechanisms are targets for vaccines and therapeutics.
Maternofetal Transfer Disorders
FcRn-mediated IgG transport across the placenta is essential for neonatal immunity. Disruptions in this process can lead to increased susceptibility to infections in newborns. Understanding FcRn-IgG binding is critical for managing maternal-fetal health.
Therapeutic Antibody Clearance
FcRn binding determines the half-life of therapeutic IgG antibodies. Engineering Fc regions to modulate FcRn affinity can extend or reduce antibody persistence. Species differences in FcγR binding affect preclinical testing of therapeutic antibodies.
From IgG binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FcRn mediate IgG transcytosis? | FCGRT knockout cell line |
| How does pH affect IgG binding? | Point mutations in FcRn histidine residues |
| Can engineered IgG-binding proteins be used for purification? | Knock-in of protein A/G domains |
| What is the role of FcγR glycosylation in IgG binding? | Overexpression of glycosylation mutants |
| How do FCGR2A polymorphisms affect autoimmune risk? | Knock-in mice with human FCGR2A variants |
| Can HSV-2 gE be targeted for vaccine? | gE knockout virus |
How to Study the IgG binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| SPR | Binding kinetics and affinity | Characterizing FcRn-IgG interaction |
| ITC | Thermodynamic parameters | Comparing IgG binding mutants |
| Flow cytometry | Cell surface IgG binding | FcγR expression profiling |
| Cryo-EM | 3D structure of complexes | Visualizing FcRn-IgG binding |
| ELISA | IgG binding specificity | Screening pathogen IgG-binding proteins |
| Pull-down assay | Protein-protein interactions | Identifying novel IgG-binding proteins |
| Computational docking | Predicted binding modes | Designing pH-sensitive IgG binders |
Surface Plasmon Resonance (SPR)
SPR measures real-time binding kinetics between IgG and its binding partners, providing affinity constants and kinetic rates.
Isothermal Titration Calorimetry (ITC)
ITC quantifies thermodynamic parameters of IgG binding, including enthalpy and entropy changes.
Flow Cytometry
Flow cytometry assesses IgG binding to cell surface receptors, such as FcγRs on immune cells.
Cryo-Electron Microscopy
Cryo-EM resolves the structural basis of IgG binding to FcRn and Fcγ receptors at near-atomic resolution.
How CRISPR Can Be Used to Study GO:0019864 IgG binding
Knockout
CRISPR knockout of FCGRT or FCGR genes abolishes IgG binding, enabling studies of FcRn-mediated transport and immune complex clearance.
Point Mutation
Point mutations in FCGR2A (H131R) or FCGR3A (V158F) alter IgG binding affinity and can model human autoimmune susceptibility.
Knock-in
Knock-in of human FCGR genes into mice humanizes the IgG binding profile, improving preclinical testing of therapeutic antibodies.
Overexpression
Overexpression of HSV-2 gE or streptococcal IgG-binding proteins in cell lines allows study of pathogen immune evasion mechanisms.
How EDITGENE Supports IgG binding Research
Researchers studying IgG binding-related genes often need to determine whether a candidate gene is causally involved in IgG recognition, transport, or immune evasion. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for IgG binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FCER1G Knockout HEK293 Cell Line | EDJ-KQ1704 | Human | 2207 | Details Get a Quote |
| PIP Knockout HEK293 Cell Line | EDJ-KQ3162 | Human | 5304 | Details Get a Quote |
| C1QB Knockout HEK293 Cell Line | EDJ-KQ4155 | Human | 713 | Details Get a Quote |
| FCGRT Knockout HEK293 Cell Line | EDJ-KQ4579 | Human | 2217 | Details Get a Quote |
| FCGR2C Knockout HEK293 Cell Line | EDJ-KQ6460 | Human | 9103 | Details Get a Quote |
| UMOD Knockout HEK293 Cell Line | EDJ-KQ16030 | Human | 7369 | Details Get a Quote |
| FCGR2A Knockout HEK293 Cell Line | EDJ-KQ17776 | Human | 2212 | Details Get a Quote |
| FCGR2B Knockout HEK293 Cell Line | EDJ-KQ17777 | Human | 2213 | Details Get a Quote |
| FCGRT Knockout HeLa Cell Line | EDJ-KQ25984 | Human | 2217 | Details Get a Quote |
| FCGRT Knockout A-549 Cell Line | EDJ-KQ27240 | Human | 2217 | Details Get a Quote |
| FCGR2C Knockout A-549 Cell Line | EDJ-KQ30542 | Human | 9103 | Details Get a Quote |
| FCGR2C Knockout HCT 116 Cell Line | EDJ-KQ30543 | Human | 9103 | Details Get a Quote |
| FCGR2C Knockout HeLa Cell Line | EDJ-KQ30544 | Human | 9103 | Details Get a Quote |
| Fcer1g Knockout RAW 264.7 Cell Line | EDJ-KZ25 | Mouse | 14127 | Details Get a Quote |
| Umod Knockout RAW 264.7 Cell Line | EDJ-KZ75 | Mouse | 22242 | Details Get a Quote |
Displaying Records 1 To 15 Of 47 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About IgG binding
What is GO:0019864?
GO:0019864 is the Gene Ontology term for IgG binding, defined as binding to an immunoglobulin of an IgG isotype.
What genes are involved in IgG binding?
Key genes include FCGRT, B2M, FCGR1A, FCGR2A, FCGR2B, FCGR3A, FCGR3B, and pathogen genes like HSV-2 gE.
How does FcRn bind IgG?
FcRn binds the Fc region of IgG in a pH-dependent manner, with high affinity at acidic pH and low affinity at neutral pH.
What is the role of IgG binding in immunity?
IgG binding mediates antibody effector functions, placental transfer, and immune complex clearance.
Which diseases are associated with IgG binding?
Autoimmune diseases, infections, and maternofetal transfer disorders are linked to IgG binding.
How can I study IgG binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of IgG-binding genes.
What methods measure IgG binding?
SPR, ITC, flow cytometry, cryo-EM, ELISA, and pull-down assays are commonly used.
What is the difference between FcRn and Fcγ receptors?
FcRn transports and recycles IgG, while Fcγ receptors mediate immune cell activation.
Can IgG binding be targeted therapeutically?
Yes, engineering Fc regions to modulate FcRn binding can extend antibody half-life, and blocking FcγR interactions is explored in autoimmunity.
What are pathogen IgG-binding proteins?
Proteins like HSV-2 gE and streptococcal proteins that bind IgG to evade host immunity.
Conclusion
GO:0019864 (IgG binding) is a fundamental molecular function with broad implications for immunity, disease, and biotechnology. From FcRn-mediated transport to pathogen immune evasion, IgG binding shapes host-pathogen interactions and therapeutic outcomes. CRISPR-based models and advanced biophysical methods continue to unravel the complexities of IgG binding, offering new avenues for drug development and vaccine design. EDITGENE stands ready to support these efforts with tailored gene editing and screening services.
References
- 1. Ljungars A et al.. 2020. A bispecific IgG format containing four independent antigen binding sites.. Sci Rep 10(1):1546 PMID: 32005942
- 2. Kristoffersen EK. 1996. Human placental Fc gamma-binding proteins in the maternofetal transfer of IgG.. APMIS Suppl 64:5-36 PMID: 8944053
- 3. Abdiche YN et al.. 2015. The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity.. MAbs 7(2):331-43 PMID: 25658443
- 4. Galli JD et al.. 2022. Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development.. Vaccines (Basel) 10(2) PMID: 35214644
- 5. Ermert D et al.. 2019. The Molecular Basis of Human IgG-Mediated Enhancement of C4b-Binding Protein Recruitment to Group A Streptococcus.. Front Immunol 10:1230 PMID: 31214187
- 6. Egli J et al.. 2019. The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies.. Pharm Res 36(3):47 PMID: 30721414
- 7. Strauch EM et al.. 2014. Computational design of a pH-sensitive IgG binding protein.. Proc Natl Acad Sci U S A 111(2):675-80 PMID: 24381156
- 8. Chaudhury C et al.. 2006. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.. Biochemistry 45(15):4983-90 PMID: 16605266
